<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
POSSIS MEDICAL, INC
- --------------------------------------------------------------------------------
(Exact name of issuer as specified in charter)
2905 Northwest Boulevard, Minneapolis, Minnesota 55441
- --------------------------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (612) 550-1010
--------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of security Common Stock, $.40 par value
-----------------------------------------------------
2. Number of shares outstanding before the change 9,970,781
------------------------
3. Number of shares outstanding after the change 11,720,781
------------------------
4. Effective date of change October 6, 1995
----------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury, etc.)
Public Offering
---------------------------------------------------------------------------
Give brief description of transaction Public offering of 1,910,000
shares of common stock (1,750,000 shares sold by Possis Medical, Inc. and
--------------------------------------------------------------------------
160,000 shares sold by certain selling shareholders) at a price of $14.50
---------------------------------------------------------------------------
per share
------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
--------------------------------------------------
2. Name after change
-----------------------------------------------------
3. Effective date of charter amendment changing name
---------------------
4. Date of shareholder approval of change, if required
-------------------
Date October 16, 1995 /s/ Irving R. Colacci
------------------- -----------------------
Vice President, Legal Affairs and Human
Resources, General Counsel and Secretary
(Officer's signature and title)
